Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of acellular pertussis vaccine alone or with tetanus-diphtheria in healthy adults
TCTR20140703001Phase 2Completed
- Sponsor
- BioNet
- Start
- Jun 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of acellular pertussis vaccine in pertussis, Tetanus, diphtheria, sponsored by BioNet. Started Jun 2014; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisTetanusdiphtheria
Beyond the preview
Go deeper on TCTR20140703001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20140703001.